u/UnfairRazzmatazz987 · 6h ago1 prior · 100% at 3mo
$CMPS Next Stop $30
After-hours price action suggests a breakout above $17 resistance could drive Compass Pathways to $30 per share.
At post $14.04Now $14.040.0% since postedas of Sep 8, 4:30 PM ET
Past performance does not predict future results. Informational only, not investment advice.
After-hours price action suggests a breakout above $17 resistance could drive Compass Pathways to $30 per share.
CMPS is positioned to become a leader in psychedelic medicine with COMP360 in Phase 3 for treatment-resistant depression and FDA breakthrough therapy designation. Approval would unlock a massive new treatment category, making $40 a realistic target that still undervalues the company's market opportunity.
End of results.